Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 43.69 | 34.88 |
PEG Ratio (TTM) | -1.46 | 8.15 |
P/S Ratio (TTM) | 0.31 | 1.41 |
P/B Ratio (TTM) | 9.10 | 4.60 |
P/FCF Ratio (TTM) | 6.89 | 17.50 |
Price to 5YR AVG Earnings Ratio | N/A | -56.91 |
Price to 5YR AVG FCF Ratio | N/A | 17.93 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.35% | 2.30% |
ROE (TTM) | 20.71% | 21.32% |
Net Profit Margin (TTM) | 0.75% | -5.00% |
ROIC 5YR AVG | N/A | 19.42% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -163.82% | 22.76% | N/A |
Revenue | 18.97% | 145.16% | N/A |
Net Income | -167.72% | 75.00% | N/A |
Cash Flow | 1,889.34% | 112.13% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.19 | 1.26 |
Quick Ratio (TTM) | 1.16 | 1.21 |
D/E Ratio (TTM) | 6.08 | 1.00 |
Interest Coverage (TTM) | 2.20 | 0.18 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 2.66 | 2.05 |
LTL to 5YR AVG FCF | N/A | 5.01 |
Shares Outstanding Growth 5YR AVG | N/A | 15.79% |